Literature DB >> 7833928

The gene for hereditary breast-ovarian cancer, BRCA1, maps distal to EDH17B2 in chromosome region 17q12-q21.

P Tonin1, O Serova, J Simard, G Lenoir, J Feunteun, K Morgan, H Lynch, S Narod.   

Abstract

A gene for hereditary breast and ovarian cancer, BRCA1, has been mapped to chromosome 17q12-q21. This gene is responsible for cancer susceptibility in the majority of families with multiple cases of ovarian cancer and early-onset breast cancer. We report linkage results of a family with 10 cases of breast cancer and a single case of ovarian cancer. A recombinant event in this family places BRCA1 distal (telomeric) to the locus EDH17B2, which codes for the enzyme estradiol 17 beta-dehydrogenase II. This recombinant is based on the appearance of breast cancer in a 45 year old woman. Under our genetic model, we estimate the probability that this woman carries a BRCA1 mutation to be 94%. These data further reduce the region of assignment of BRCA1 on chromosome 17q12-q21 and should expedite positional cloning of this important gene.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7833928     DOI: 10.1093/hmg/3.9.1679

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  12 in total

1.  Evidence for effective suppression of recombination in the chromosome 17q21 segment spanning RNU2-BRCA1.

Authors:  X Liu; D F Barker
Journal:  Am J Hum Genet       Date:  1999-05       Impact factor: 11.025

2.  Molecular and genealogical characterization of the R1443X BRCA1 mutation in high-risk French-Canadian breast/ovarian cancer families.

Authors:  Hélène Vézina; Francine Durocher; Martine Dumont; Louis Houde; Csilla Szabo; Martine Tranchant; Jocelyne Chiquette; Marie Plante; Rachel Laframboise; Jean Lépine; Heli Nevanlinna; Dominique Stoppa-Lyonnet; David Goldgar; Peter Bridge; Jacques Simard
Journal:  Hum Genet       Date:  2005-05-10       Impact factor: 4.132

3.  Evidence for genetic anticipation in non-Mendelian diseases.

Authors:  A D Paterson; J L Kennedy; A Petronis
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

4.  Recessive oncogenes: current status.

Authors:  Xiang Gao; Kenneth V Honn
Journal:  Pathol Oncol Res       Date:  1995       Impact factor: 3.201

5.  Human immunodeficiency virus type 1-like DNA sequences and immunoreactive viral particles with unique association with breast cancer.

Authors:  E M Rakowicz-Szulczynska; B Jackson; A M Szulczynska; M Smith
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

6.  Linkage analysis of 26 Canadian breast and breast-ovarian cancer families.

Authors:  P Tonin; R Moslehi; R Green; B Rosen; D Cole; N Boyd; C Cutler; R Margolese; R Carter; B McGillivray
Journal:  Hum Genet       Date:  1995-05       Impact factor: 4.132

7.  A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families.

Authors:  O Serova; M Montagna; D Torchard; S A Narod; P Tonin; B Sylla; H T Lynch; J Feunteun; G M Lenoir
Journal:  Am J Hum Genet       Date:  1996-01       Impact factor: 11.025

8.  An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium.

Authors:  S A Narod; D Ford; P Devilee; R B Barkardottir; H T Lynch; S A Smith; B A Ponder; B L Weber; J E Garber; J M Birch
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

Review 9.  BRCA1 and BRCA2 mutations in breast and ovarian cancer syndrome: reflection on the Creighton University historical series of high risk families.

Authors:  Olga M Sinilnikova; Sylvie Mazoyer; Colette Bonnardel; Henry T Lynch; Steven A Narod; Gilbert M Lenoir
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

10.  BRCA germline mutations in Jewish patients with pancreatic adenocarcinoma.

Authors:  Cristina R Ferrone; Douglas A Levine; Laura H Tang; Peter J Allen; William Jarnagin; Murray F Brennan; Kenneth Offit; Mark E Robson
Journal:  J Clin Oncol       Date:  2008-12-08       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.